Annual Drug Patent Expirations for ADVAIR+HFA
Advair Hfa is a drug marketed by Glaxo Grp Ltd and is included in one NDA. It is available from one supplier. There are three patents protecting this drug.
Drug patent litigation for ADVAIR HFA.
This drug has thirty patent family members in fourteen countries.
The generic ingredient in ADVAIR HFA is fluticasone propionate; salmeterol xinafoate. One supplier is listed for this compound. Additional details are available on the fluticasone propionate; salmeterol xinafoate profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
